Total Assets: The sum of all assets on a company's balance sheet.
Monte Rosa Therapeutics, Inc. (GLUE) had Total Assets of $448.66M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$123.67M |
|
$-38.63M |
|
-- |
|
$123.67M |
|
$177.88M |
|
$-54.21M |
|
$14.48M |
|
$-39.72M |
|
$-39.78M |
|
$-38.63M |
|
$-38.63M |
|
$-38.63M |
|
$-38.69M |
|
$-54.21M |
|
$-45.85M |
|
83.07M |
|
83.07M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$393.19M |
|
$25.99M |
|
$55.47M |
|
|
Total Assets |
$448.66M |
$64.21M |
|
-- |
|
$151.39M |
|
$215.60M |
|
$233.06M |
|
$233.06M |
|
$233.06M |
|
65.54M |
|
| Cash Flow Statement Financials | |
$-22.80M |
|
$-101.83M |
|
$30.35M |
|
$229.12M |
|
$134.84M |
|
$-94.28M |
|
$18.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-43.83% |
|
-43.83% |
|
-37.08% |
|
-32.12% |
|
-31.23% |
|
$-27.50M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
-- |
|
10.66 |
|
34.24 |
|
-16.57% |
|
-16.57% |
|
-8.61% |
|
-16.57% |
|
$3.56 |
|
$-0.33 |
|
$-0.27 |
|